HI-DOXI 500® is an antimicrobial bacteriostatic, belonging to the group second generation tetracyclines, which acts by inhibiting bacterial protein synthesis. It has a broad antimicrobial spectrum of action which encompasses Gram-positive bacteria, Gram-negative bacteria, chlamydia, mycoplasmas, rickettsia, actinomycetes, spirochetes and some protozoa. It is characterized by its high lipid solubility, for a quick and efficient travel through physiological membranes, obtaining greater intestinal absorption and high bioavailability and a better distribution in the body, mainly in the respiratory tract.
HI-DOXI 500® presents low bacterial resistance.
HI-DOXI 500® is indicated for the prevention and treatment of chronic respiratory disease caused by Mycoplasma gallisepticum and Mycoplasma synoviae, Haemophilus paragallinarum, Rhinotracheale ornithobacterium and e.coli.
Doxycycline (hyclate form) 50%
Bags of 5, 10 and 20 kg.